For comments, suggestions
Created with Raphaël 2.1.0 11.07.2019 Filing date 08.01.2021 Validation fee payment 31.03.2021 (A1) Patent application published

Patent not validated (the request for validation was not submitted on time)


(210)Number of the EPO application19185896
(220)Filing date of the EPO application2019.07.11
(80)EPO patent specification publication (B)EPB nr. 45/2021, 2021.11.10
(110)EPO patent number3677278
(21)Number of the applicatione 2021 0112
(71)Name(s) of applicant(s), code of the countryScholar Rock, Inc., US;
(72)Name(s) of inventor(s), code of the countryDATTA Abhishek, US;
CAPILI Allan, US;
SCHURPF Thomas, US;
MARTIN Constance, US;
DAGBAY Kevin B., US;
CHAPRON Christopher, US;
WAWERSIK Stefan, US;
LITTLEFIELD Christopher, US;
CARVEN Gregory J., US;
BUCKLER Alan, US;
LIN Susan, US;
JACKSON Justin W., US;
COOPER Anthony, US;
AVERY Andrew, US;
SALOTTO Matthew, US;
STEIN Caitlin, US;
(73)Name(s) of owner(s), code of the countryScholar Rock, Inc., US;
(54)Title of the inventionISOFORM SELECTIVE TGFBETA1 INHIBITORS AND USE THEREOF
(13)Kind-of-document code A1
(51)International Patent Classification C07K 16/22 (2006.01.01); C07K 16/28 (2006.01.01); A61K 45/06 (2006.01.01); A61K 49/00 (2006.01.01); A61P 1/16 (2006.01.01); A61P 13/12 (2006.01.01); A61P 35/00 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2021.03.31
(30)Priority201862696752 P, 2018.07.11, US; 201862696774 P, 2018.07.11, US; 201862718196 P, 2018.08.13, US; 201862722081 P, 2018.08.23, US; 201862737534 P, 2018.09.27, US; 201862758180 P, 2018.11.09, US; 201862757917 P, 2018.11.09, US; 201962810263 P, 2019.02.25, US; 201962827552 P, 2019.04.01, US
Up
/Inventions/details/3677278